Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Accord Healthcare
Accord Healthcare
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Carthera signs strategic collaboration with Accord Healthcare
Partnership will further development, manufacturing and commercialisation of carboplatin to be used with SonoCloud system for the treatment of recurrent glioblastoma
Analysis
Accord Healthcare implements next generation of Ci-DMS
The project has already reaped many benefits including greater accuracy and efficiency when dispensing material weights
Media
Accord Healthcare opens new UK factory to increase EU presence
New site to be EMENA centre for excellence and create more than 500 jobs
Pharmaceutical
Intas first Indian company to launch biosimilar in EU, US and Japan
The company has launched its first biosimilar, filgrastim, in Europe, through its wholly owned subsidiary Accord Healthcare
Subscribe now